Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

Nephrology Dialysis Transplantation

Volumn 20, Issue 10, 2005, Pages 2178-2185

  Mudge, David W ^a   Rogers, Robyn ^a   Hollett, Peter ^a   Law, Belinda ^a   Reiger, Kylie ^a   Petrie, James J B ^a   Price, Lee ^a   Johnson, David W ^a   Campbell, Scott B ^a   Isbel, Nicole M ^a   Sullivan, Matthew ^a   Hawley, Carmel M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Dialysis; Dialyzer membrane; FX class dialyzer; Haemodialysis; High flux; Plasma homocysteine

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; DRUG DOSE REGIMEN; FEMALE; HEMODIALYSIS; HUMAN; MALE; OUTCOMES RESEARCH; PLASMA CLEARANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 27144511305     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh987     Document Type: Article

References (20)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057
2. Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141
3. Mallamaci F, Zoccali C, Tripepi G et al. Hyper-homocysteinemia predicts cardiovascular outcomes in hemo-dialysis patients. Kidney Int 2002; 61: 609-614
4. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004; 15: 4421-453
5. Bostom AG, Shemin D, Gohh RY et al. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Kidney Int Suppl 2001; 78: S246-S252
6. Righetti M, Tommasi A. Lagona C, La RL, Uccellini M, Sessa A. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients. Perit Dial Int 2004; 24: 373-377
7. Blankestijn PJ, Vos PF, Rabelink TJ, van Rijn HJ, Jansen H, Koomans HA. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 1995; 5: 1703-1708
8. Seres DS, Strain GW, Hashim SA, Goldberg IJ, Levin NW. Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 1993: 3: 1409-1415
9. Docci D, Capponcini C, Mengozzi S, Baldrati L, Neri L, Feletti C. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron 1995; 69: 323-326
10. House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC. Randomized trial of high-flux vs low-flux haemodialysis: Effects on homocysteine and lipids. Nephrol Dial Transplant 2000; 15: 1029-1034
11. van Tellingen A, Grooteman MP, Bartels PC et al. Long-term reduction of plasma homocysteine levels by superflux dialyzers in hemodialysis patients. Kidney Int 2001; 59: 342-347
12. De Vriese AS, Langlois M, Bernard D et al. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2596-2600
13. Galli F, Benedetti S, Buoncristiani U et al. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 2003; 64: 748-755
14. Krieter DH, Canand B. High permeability of dialysis membranes: What is the limit of albumin loss? Nephrol Dial Transplant 2003; 18: 651-654
15. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: A common mutation in methylene-tetrahydrofolate reductase. Nat Genet 1995; 10: 111-113
16. Depner TA, Rizwan S. Cheer AY, Wagner JM, Eder LA. High venous urea concentrations in the opposite arm. A consequence of hemodialysis-induced compartment disequilibrium. ASAIO Trans 1991; 37: M141-M143
17. Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995; 41: M719-M724
18. Daugirdas JT, Depner TA, Gotch FA et al. Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study. Kidney Int 1997; 52: 1395-1405
19. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics 1988; 44: 1049-1060
20. Buoncristiani U. Dramatic improvement of uraemic anaemia over a 6-month treatment with protein-leaking dialysers. J Am Soc Nephrol 2000; 11: 259A (Abstract)